Artificial tears

Generic name
Artificial tears
Brand name
ATC Code
S01XA20

Artificial tears

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information on pharmacokinetic parameters in children.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Reduced tear secretion/dehydration
  • Ocular
    • 0 years up to 18 years
      • 1 drop(s)/dose, as required, max. every hour.
      • Do not apply indifferent gel or drops containing preservatives more than 4 times a day, as the preservatives (especially benzalkonium) can be toxic to the corneal epithelium. (NHG standard The red eye)

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

OTHER OPHTHALMOLOGICALS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

OVERIGE MIDDELEN VOOR OOGHEELKUNDIG GEBRUIK
S01XA20
S01XA20
S01XA20
S01XA21
S01XA20
S01XA20
S01XA20
S01XA
Other ophthalmologicals
S01XA20
S01XA20
S01XA20
S01XA21
S01XA20
S01XA20
S01XA20
S01XA

References

  1. Bausch & Lomb Pharma nv, SmPC Liposic ooggel 2 mg/g ( RVG 107234) 14--11-2018, www.geneesmiddeleninformatiebank.nl
  2. Allergan Pharmaceuticals Ireland, SmPC Cellufluid oogdruppels (RVG 33209) 15-5-2014, www.geneesmiddeleninformatiebank.nl
  3. Bausch & Lomb Pharma nv, SmPC Artelac (RVG 32370) 14-08-2015, www.geneesmiddeleninformatiebank.nl
  4. Bolsius EJM et al, Dutch General Practitioners guideline " The red eye" , www.richtlijnen.nhg.org, 2017
  5. Bolsius EJM et al, Dutch General Practitioners guideline " The red eye", www.richtlijnen.nhg.org, 2017

Changes

Therapeutic Drug Monitoring


Overdose